Company intelligence / Profile preview

Yifan Pharmaceutical

Hangzhou, Zhejiang, Chinaen.yifanyy.com ↗

Ownership: Private
Employees: ~5000
Development stage: Commercial

Overview

Yifan has a diversified pipeline with over 30 marketed drugs and more than 20 clinical trials ongoing. Recent approvals include Ryzneuta for neutropenia in the EU. The company is advancing several innovative biologics into global clinical development across liver diseases, oncology, endocrinology/metabolic disorders, pediatrics and infectious diseases. Their platforms support both novel drug discovery and biosimilar development.

Therapeutic areas: OncologyEndocrinologyImmunologyHematologyPsychiatryGastroenterologyInfectious Diseases
Modalities: Small moleculeBiologicSynthetic biologicTraditional Chinese medicine (TCM)
Industry: Biotech

Drug pipeline

19 assets

Compound Huangdai Tablet

18 more assets in the full pipeline.

Request access →

Partnerships

Bayer HealthCare – commercialization agreement for Stivarga and NexavarCollaborations with top synthetic biologics companies domestically/internationally

Beyond the preview

Go deeper on Yifan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yifan Pharmaceutical.

Explore the full profile